Friday, April 19, 2019
    Latest

    Multiple Sclerosis

    Home Multiple Sclerosis
    MS
    Multiple Sclerosis

    Cedars-Sinai-Led Research Reveals Nearly 20% of People with MS are Misdiagnosed!

    0
    Multiple Sclerosis

    Novartis Drug Wins FDA Approval Despite Challenges to its $88K Price

    0
    Multiple Sclerosis
    Multiple Sclerosis

    UCSF EMR Drives RWD for Compelling Multiple Sclerosis Research Results

    0
    Multiple Sclerosis

    Cleveland Clinic Nevada Joins the DELIVER-MS Clinical Trial

    0
    Multiple Sclerosis

    Investigator Profile: Dr. Benjamin Segal Joins Ohio State University Wexner Medical...

    0
    Multiple Sclerosis

    Celgene Funded Study Finds Incidence of Depression Nearly 100% Higher than...

    0
    Multiple Sclerosis

    FDA Reviewing Alkermes & Biogen Multiple Sclerosis Treatment by Q4 2019

    0
    MS APP
    Multiple Sclerosis

    Genentech Launches MS Patient Smartphone App

    0
    MS
    Multiple Sclerosis

    Cleveland Clinic First Contracted Site for MS Clinical Trial

    0
    Multiple Sclerosis

    PriceWatch: MS Drug Costs May Skyrocket For Medicare Beneficiaries

    0
    123Page 1 of 3
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    307 West 200 South #5002
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved